https://newsletter.glp1studio.com/p/telehealth-startups-push-glp-1s-offGLP-1 Studioen2026-10-23T17:00:00+00:00Telehealth startups push GLP-1s off-label for addictionhttps://newsletter.glp1studio.com/p/roche-plans-a-head-to-head-trialGLP-1 Studioen2026-10-23T17:00:00+00:00Roche plans a head to head trial of enicepatide against tirzepatide